Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Xianglong Pharmaceutical Technology is a specialized chemical enterprise focused on the research, development, and production of pharmaceutical intermediates and fine chemicals. Based in the Changzhou National High-tech District in China, the company provides a diverse portfolio of chemical building blocks, including pyridine derivatives, benzene derivatives, and various heterocyclic compounds. They primarily serve the global pharmaceutical industry by supplying high-quality materials essential for the synthesis of active pharmaceutical ingredients (APIs). In addition to catalog products, the company offers custom synthesis and contract manufacturing services tailored to specific client requirements. Their operations emphasize technical innovation and rigorous quality control to support drug discovery and development pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Xianglong Pharmaceutical Technology.